Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115447) titled 'Research on the diagnostic efficacy of calcitriol inhibition test for hyperparathyroidism' on Dec. 26, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Department of Endocrinology and Metabolism, West China Hospital, Sichuan University
Condition:
Metabolic bone disease
Intervention:
Calcitriol intervention group:Calcitriol 0.25ug tid*3 days will be administered
After the calcitriol inhibition test was completed, vitamin D supplementation was given ( - vitamin D3 5000IU once a day
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target...